Chemours Faces Securities Fraud Lawsuit After Opteon Demand Issues Trigger 18% Stock Drop
5 days ago
Chemours faces a securities fraud lawsuit following an 18.63% stock drop due to alleged misrepresentation of Opteon demand. Investors have until December 7, 2026, to join the class action amid claims of oversupply due to U.S. AIM Act transition.
Show all 48 updates